Novo Nordisk | NVO - EPS Earnings Per Share


Novo Nordisk reported DKK1.02 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2024Q3 Sep/2024 6.12 0.88 5.00 Nov/06 2024
FY2024Q2 Jun/2024 4.49 4.32 Aug/07 2024
FY2024Q1 Mar/2024 5.68 4.39 May/02 2024
FY2023Q4 Dec/2023 0.72 0.67 6.02 Jan/31 2024
FY2023Q3 Sep/2023 5.00 0.68 6.34 Nov/02 2023




Eps Change Date
ANI Pharmaceuticals USD 2.04 0.24 Sep/2025
Aurora Cannabis CAD -1 0.73 Sep/2025
Bausch Health Companies USD 1.08 0.08 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Canopy Growth CAD -0.08 0.14 Sep/2025
Corcept Therapeutics USD 0.16 0.13 Sep/2025
Drreddys Laboratories INR 0.16 0.04 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Novartis USD 2.04 0.38 Sep/2025
Novo Nordisk DKK 6.04 1.54 Dec/2025
Novo Nordisk DKK 1.02 0.1 Dec/2025
Pacira USD 0.7 0.04 Sep/2025
Perrigo USD 0.8 0.23 Sep/2025
Phibro Animal Health USD 0.08 0.09 Dec/2024
Prestige Brands USD 1.14 0.07 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Supernus Pharmaceuticals USD -0.8 1.2 Sep/2025
Zoetis USD 1.48 0.22 Dec/2025